Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Home > Researchers > Funding opportunities > 23/114 Palliative and End of Life Care (HTA Programme)

23/114 Palliative and End of Life Care (HTA Programme)

Opens

31 August 2023

Closes

13:00 on 03 January 2024

Contact

  • For help with your application contact htafunding@nihr.ac.uk
  • For more information about the funding Programme, visit the HTA Page
  • Got a research idea and not sure how to turn it into a funding application? The Research Design Service (RDS) supports health and social care researchers across England on all aspects of developing and writing a funding application. Find out how the RDS can help with your application.

Supporting Information

Please note that the Word version of the Stage 1 application form is to be used as a guide and to assist with completion of the online application form only, for example to see how many characters are accepted in each section and how the printed complete form is laid out. Please do not try to use this as an application form, you must apply using the online form available through the links available when calls are open. You should also refer to the application form guidance notes.

Studies within a trial or a review

  • This funding opportunity is eligible for researchers to embed a study within a trial or a review. These studies should evaluate alternative ways of undertaking a trial or a review process.

The Health Technology Assessment (HTA) Programme invites applications for palliative and end of life care research which supports health and care services to help people at the end of their lives to live as well as possible and to die with dignity, compassion and comfort.

The HTA Programme welcomes research proposals in any disease, service or setting, including, but not limited to:

  • hospitals
  • specialist centres and services
  • community services
  • home and care homes

In addition to the specific areas noted in the commissioning brief, research proposals should address inequalities in access and experience of care and services, including intersectional differences and disadvantage. To build capacity and address geographical and other disparities in research funding and activity, we welcome partnerships between research active institutions and others less active to date, and located in geographical areas of deprivation and/or high care need.

Other NIHR funding programmes are involved in this call are:

Given its scope, we welcome applications that span the remit of 1 or more of the participating research programmes, and which comprise of co-ordinated teams of investigators spanning different specialties/disciplines.

In order to apply you will need to carefully review the:

Applications received by the advertised closing date will be considered at a first-stage funding committee meeting, and successful applicants will then be invited to submit a Stage 2 application. Applicants will have 8 weeks to complete and submit their Stage 2 application form, which will then be considered at the following HTA funding committee meeting.

All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the Research Governance Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.

Studies within a trial or review

This funding opportunity is eligible for a SWAT/SWAR (study within a trial or study within a review), which can help significantly improve methodology of future research as well as the host study. Find out about the benefits of SWATs/SWARs and how to include one in your application. 

Timescales

Any changes to these dates will be emailed to all Lead Applicants with an application in progress.

  • Stage 1 deadline: 1pm, 3 January 2024
  • notification of out of remit/non-competitive decision if unsuccessful: early February 2024
  • notification of Stage 1 shortlisting decision: March 2024
  • Stage 2 writing window: March 2024 to June 2024
  • notification of Stage 2 funding decision: late August/early September 2024
  • start date for funded studies: April/May 2025